Showing 2,041 - 2,060 results of 14,940 for search '(( significant ((we decrease) OR (greatest decrease)) ) OR ( significantly increased decrease ))', query time: 0.68s Refine Results
  1. 2041

    Original images for explaining Fig 4. by Reiri Takeuchi (20460788)

    Published 2024
    “…Treatment with cyclosporine A also increased <i>MYC</i> and <i>ATM</i> mRNA expression levels and decreased <i>CDK2</i>, <i>ATR</i>, <i>P27</i>, <i>P53</i> and <i>RB1</i> mRNA expression levels but not significantly. …”
  2. 2042

    Calycosin Inhibit PANoptosis and Alleviate Brain Damage: A Bioinformatics and Experimental Verification Approach by Huiyan An (20959966)

    Published 2025
    “…The results demonstrate that Calycosin could improve the cell growth of HT22, leading to enhanced cell viability, reduced lactate dehydrogenase leakage, and decreased cell apoptosis after OGD/R. It also regulated the expression of PANoptosis-related genes such as NLRP3, GSDMD, MLKL, and RIPK1 and increased the Bcl-2/Bax ratio, effectively reducing cellular damage and providing protection. …”
  3. 2043

    Basic characteristics of the afforested land. by Yao Zhong (280645)

    Published 2025
    “…The results revealed that land use significantly altered the distribution of carbon fractions. …”
  4. 2044

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  5. 2045

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  6. 2046

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  7. 2047

    Image 4_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  8. 2048

    Image 1_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  9. 2049

    Image 3_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  10. 2050

    Image 2_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  11. 2051
  12. 2052
  13. 2053
  14. 2054
  15. 2055
  16. 2056
  17. 2057
  18. 2058
  19. 2059
  20. 2060